Creating a human model to understand Alzheimer's disease mechanisms

Establishment of a Human Microphysiological System to Elucidate Cellular Mechanisms Underlying Vulnerability to AD

NIH-funded research Brigham and Women's Hospital · NIH-11121367

This study is creating a special 3D model of the brain using cells from different people to help researchers learn more about what makes some individuals more likely to develop Alzheimer's disease, so they can find better ways to understand and treat it.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11121367 on NIH RePORTER

What this research studies

This research aims to develop a sophisticated human microphysiological system to investigate the cellular mechanisms that contribute to vulnerability to Alzheimer's disease (AD). By utilizing induced pluripotent stem cells (iPSCs) from a diverse group of participants, the study will create a 3D 'Brain-Chip' model that mimics the complex interactions between various cell types involved in AD. This innovative approach will allow researchers to better understand the genetic and biological factors that influence the onset and progression of Alzheimer's and related dementias.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of Alzheimer's disease or those who are at risk due to genetic factors.

Not a fit: Patients who are not at risk for Alzheimer's disease or do not have a family history of dementia may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights and therapeutic strategies for preventing or treating Alzheimer's disease.

How similar studies have performed: Previous research using similar organ-on-chip technologies has shown promise in understanding complex diseases, suggesting that this approach could yield valuable insights into Alzheimer's disease.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.